Dhanvantri Jeevan Rekha Ltd Stock Analysis

BSE: 531043 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price Jan 17, 18:01
20.83 0.99 (4.99%)

DeciZen - Make an Informed Decision on DhanvantriJeevan Rek

M-Cap below 100cr DeciZen not available

10 Year X-Ray:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 8.1%14.3%8.7%13.8%11.3%10.1%7.8%1.1%-2.2%-14.3%-
Value Creation Index -0.40.0-0.4-0.0-0.2-0.3-0.4-0.9-1.2-2.0-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 4.65.87.389.311.213.716.818.29.815
YoY Gr. Rt. %-25.8%26.3%9.8%16.2%20.6%23%22.5%8.2%-46.3%-
Adj EPS 12.11.42.42.32.11.80.1-0.6-3.51
YoY Gr. Rt. %-99%-33.7%77.9%-3.7%-10.7%-14.4%-93.8%-681.8%NA-
BVPS (₹) 12.814.816.120.522.824.125.92625.421.923
Adj Net Profit 0.40.80.6110.90.70.1-0.3-1.40
Cash Flow from Ops. 1.21.11.20.81.33.50.91.31.4-0.4-
Debt/CF from Ops. 0.40.10.10002.20.10.1-0.2-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 8.8%1.1%-10.7%-46.3%
Adj EPS -214.5%-208.3%-224.9%NA
BVPS 6.2-0.8-5.4-13.7
Share Price 13.8% -15.5% 7.5% 212.3%

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 8.314.78.713.110.78.87.10.4-2.5-14.64.3
Op. Profit Mgn % 20.925.918.319.215.614.413.57.33.7-7.77.2
Net Profit Mgn % 9.314.67.712.410.37.65.30.3-1.5-14.62.7
Debt to Equity 0.1000000.20000
Working Cap Days 11562531251741228271638859
Cash Conv. Cycle 222520232412122017120

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 4.30%

Sales growth is good in last 4 quarters at 68.95%

Sales growth has been subdued in last 3 years -10.71%

Net Profit has been subdued in last 3 years -224.92%

Latest Financials - Dhanvantri Jeevan Rekha Ltd.

Standalone Consolidated
TTM EPS (₹) 1 -
TTM Sales (₹ Cr.) 14.6 -
BVPS (₹.) 23 -
Reserves (₹ Cr.) 5 -
P/BV 0.91 -
PE 21.61 -
From the Market
52 Week Low / High (₹) 5.83 / 19.84
All Time Low / High (₹) 3.69 / 61.70
Market Cap (₹ Cr.) 8.5
Equity (₹ Cr.) 4.1
Face Value (₹) 10
Industry PE 82.7

Management X-Ray:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

It offers diagnostic and therapeutic facilities in all specialities, well equipped multidisciplinary intensive care units and cashless hospitalization for accredited patients.

The company is basically engaged in offering different medical facilities like Cardiac Care, Endourology, Gastroenterology, Neuro Surgery, Neurology, Anestheslogy and Orthopedic Surgery.

The company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging  (MRI). The company obtained certificate for commencement of business on August 2, 1993. The company was incorporated  with an authorized capital of Rs. 200 Lacs which was subsequently increased to Rs. 500 Lacs from time to time.

In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagnostic equipments in the Urology and Cardiology Sections have already been installed and are in operation. The company has acquired the adjacent plot in 2004 on which the future expansion plan is expected to commence shortly.

Services offered by the company:

  • Female Urology
  • Impotency
  • Infertility
  • Lithotripsy
  • Paediatric Urology
  • Cystometrogram
  • Uroflowmetry
  • Uro Oncology 
  • Uro Lithiasis
  • Stricture Urethra
  • Renal Transplant & Dialysis

Future plans :

  • A 100 bedded new wing
  • 30 bedded ICU.
  • Multislice spiral CT scan. 
Read More Read Less